Multiple Sclerosis Central

Tanuja Chitnis, MD, senior neurologist at Brigham and Women’s Hospital and professor of neurology at Harvard Medical School and coauthor of the new National MS Guidelines, spoke with Healio about autologous hematopoietic stem cell transplant as treatment for MS.

Jacqueline F. Rosenthal, MD, a neurologist with the Andrew C. Carlos Multiple Sclerosis Institute, spoke with Healio about symptom differences in multiple sclerosis, responses to therapies and treatments and the impact of racism in MS.

Patients with MS do not appear at higher risk for contracting COVID-19 nor for worsening complications should they contract the virus compared with the general population, according to Dina A. Jacobs, MD.

While we know women are threefold more likely than men to receive an MS diagnosis and they are usually diagnosed during their childbearing years, data on the impact of pregnancy on MS outcomes remain less clear.

Many patients with MS turn to complementary treatment to help alleviate their symptoms. The National MS Society states that most patients in the United States incorporate complementary treatment as part of their disease management.

Healio spoke with Kathryn Cauley Fitzgerald, ScD, PhD, assistant professor of neurology at Johns Hopkins University School of Medicine, about the relationship between vitamin D and MS.

Jeffrey Cohen, MD, of Mellen Center for Multiple Sclerosis at Cleveland Clinic. He spoke with Healio about how stem cells are used to treat patients with MS as well as the potential that this line of research has for the 1 million Americans with MS.

The management of multiple sclerosis has improved considerably over the past decade with broadening of the therapeutic armamentarium including the introduction of oral disease modifying therapies.